Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by trial titles, indicators and specific disease types.

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Carrollton

A phase III study of postoperative radiation therapy (IMRT) +/- cetuximab for locally-advanced resected head and neck cancer (RTOG 0920)

  • Details

ClinicalTrials.gov ID: NCT00956007
Diagnosis Type: NA
USOR Number: 10025

  • Practice Details

4352 N Josey Lane
Carrollton, TX 75010
P: (972) 394-4368

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Carrollton

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy (NSABP B-51 / RTOG 1304)

  • Details

ClinicalTrials.gov ID: NCT01872975
Diagnosis Type: NA
USOR Number: 13091

  • Practice Details

4352 N Josey Lane
Carrollton, TX 75010
P: (972) 394-4368

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Houston

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

925 Gessner Rd, Suite 100
Houston, TX 77024
P: (713) 242-3500

More Details View Practice Page

Liver Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

1800 Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Liver Cancer

Clinical Trial at: Comprehensive Cancer Centers of Nevada - Las Vegas

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

3730 S Eastern Ave
Las Vegas, NV 89169
P: (702) 952-3400

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Tyler

A Phase Ib/II Clinical Study of BBI608 in Combination with Sorafenib or BBI503 in Combination with Sorafenib in Adult Patients with Hepatocellular Carcinoma (BBI608-503-103HCC; formerly: BBIHCC-103)

  • Details

ClinicalTrials.gov ID: NCT02279719
Diagnosis Type: NA
USOR Number: 14148

  • Practice Details

910 E Houston St, Suite 100
Tyler, TX 75702
P: (903) 579-9800

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, CO 80113
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Wichita Falls

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

5400 Kell West Blvd
Wichita Falls, TX 76310
P: (940) 691-8271

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - The Woodlands

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

9200 Pinecroft, Suite 450
The Woodlands, TX 77380
P: (281) 296-0365

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Houston

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

925 Gessner Rd, Suite 100
Houston, TX 77024
P: (713) 242-3500

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, CO 80113
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Virginia Oncology Associates - Norfolk

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

5900 Lake Wright Dr
Norfolk, VA 23502
P: (757) 466-8683

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Wichita Falls

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

5400 Kell West Blvd
Wichita Falls, TX 76310
P: (940) 691-8271

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Englewood

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

499 East Hampden Ave., Suite 450
Englewood, CO 80113
P: (303) 740-8200

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Round Rock

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2410 Round Rock Ave, Suite 150
Round Rock, TX 78681
P: (512) 341-8724

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Beaumont

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

690 N 14th Street
Beaumont, TX 77702
P: (409) 899-7180

More Details View Practice Page

Lymphomas

Clinical Trial at: Virginia Oncology Associates - Chesapeake

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

725 Volvo Parkway, Suite 200
Chesapeake, VA 23320
P: (757) 549-4403

More Details View Practice Page

Lymphomas

Clinical Trial at: New York Oncology Hematology - Clifton Park

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

3 Crossing Boulevard
Clifton Park, NY 12065
P: (518) 831-4434

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

More Details View Practice Page

Lymphomas

Clinical Trial at: Maryland Oncology Hematology - Columbia

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

10710 Charter Dr, Suite G020
Columbia, MD 21044
P: (410) 964-2212

More Details View Practice Page

Pages